InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,907.20
(
-0.90%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.19
(
-0.04%
)
Bitcoin
63,521.75
(
-1.18%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

NSP

Send PM Follow Ignore
Followers 0
Posts 1
Boards Moderated 0
Alias Born 06/09/2012

NSP

Re: Just the facts maam post# 16602

Saturday, 06/09/2012 4:48:46 PM

Saturday, June 09, 2012 4:48:46 PM

Post# of 26138
Can anyone tell me how in the world BPAX will be able to file Libigel NDA application without meeting primary or secondary efficacy end points? Safety is importtant but without efficacy I am not sure. I am not a basher but I havn't heard product approved just based on safety without efficacy.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up